Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influence of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on the heart rate and blood pressure responses to graded exercise.

× No keyword cloud information.

15 in total

Review 1. A survey of the pharmacological properties of metoprolol in animals and man.

Authors: B Ablad; K O Borg; E Carlsson; L EK; G Johnson; T Malmfors; C G Regårdh
Journal: Acta Pharmacol Toxicol (Copenh) Date: 1975

2. Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.

Authors: G Johnsson; C G Regårdh; L Sölvell
Journal: Acta Pharmacol Toxicol (Copenh) Date: 1975

Review 3. Hypertension: which beta-blocker?

Authors: H J Waal-Manning
Journal: Drugs Date: 1976-12 Impact factor: 9.546

4. Physiological disposition and metabolism of timolol in man and laboratory animals.

Authors: D J Tocco; A E Duncan; F A Delauna; H B Hucker; V F Gruber; W J Vandenheuvel
Journal: Drug Metab Dispos Date: 1975 Sep-Oct Impact factor: 3.922

5. The pharmacological classification of practolol and chloropractolol.

Authors: T P Kenakin; J W Black
Journal: Mol Pharmacol Date: 1978-07 Impact factor: 4.436

6. Metabolism of a beta blocking drug, oxprenolol.

Authors: D A Garteiz
Journal: J Pharmacol Exp Ther Date: 1971-11 Impact factor: 4.030

7. Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man.

Authors: J G Wagner
Journal: J Theor Biol Date: 1968-08 Impact factor: 2.691

8. Determination of pindolol in human plasma by high-performance liquid chromatography.

Authors: M Bangah; G Jackman; A Bobik
Journal: J Chromatogr Date: 1980-08-08

9. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.

Authors: D G McDevitt; H C Brown; S G Carruthers; R G Shanks
Journal: Clin Pharmacol Ther Date: 1977-05 Impact factor: 6.875

10. Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina.

Authors: I K Bailey; S D Anderson; P J Rozea; L Bernstein; G Nyberg; P I Korner
Journal: Am Heart J Date: 1976-10 Impact factor: 4.749

11 in total

Review 1. Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Authors: D G Waller
Journal: Br J Clin Pharmacol Date: 1990-08 Impact factor: 4.335

2. Pharmacokinetic-pharmacodynamic modelling of oxprenolol in man using continuous non-invasive blood pressure monitoring.

Authors: R Koopmans; B Oosterhuis; J M Karemaker; J Wemer; C J van Boxtel
Journal: Eur J Clin Pharmacol Date: 1988 Impact factor: 2.953

3. Relationship between plasma beta-adrenoceptor blocker concentration and pharmacodynamic activity.

Authors: B Silke
Journal: Br J Clin Pharmacol Date: 1982-02 Impact factor: 4.335

4. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.

Authors: J Bonde; T L Svendsen; K Lyngborg; J Mehlsen; J Trap-Jensen
Journal: Br J Clin Pharmacol Date: 1987-01 Impact factor: 4.335

Review 9. Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors: W H Aellig
Journal: Br J Clin Pharmacol Date: 1982 Impact factor: 4.335

10. Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.

Authors: B Silke; G I Nelson; R C Ahuja; R C Okoli; S H Taylor
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

Influence of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on the heart rate and blood pressure responses to graded exercise.